Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.

Saved in:
Bibliographic Details
Title: Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
Authors: Bénard F; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada. Electronic address: fbenard@bccrc.ca., Harsini S; BC Cancer Research Institute, Vancouver, BC, Canada., Wilson D; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Zukotynski K; Department of Radiology, McMaster University, Hamilton, ON, Canada., Abikhzer G; Jewish General Hospital, Montreal, QC, Canada., Turcotte E; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Cossette M; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada., Metser U; University Health Network, Toronto, ON, Canada., Romsa J; Division of Nuclear Medicine, London Health Sciences Centre, London, ON, Canada; St Joseph's Health Care, London, ON, Canada; Western University, London, ON, Canada., Martin M; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Mar C; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Saad F; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Soucy JP; Department of Radiology, McGill University, Montreal, QC, Canada., Eigl BJ; BC Cancer Research Institute, Vancouver, BC, Canada., Black P; Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada., Krauze A; BC Cancer Research Institute, Vancouver, BC, Canada., Burrell S; Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada., Nichol A; BC Cancer Research Institute, Vancouver, BC, Canada., Tardif JC; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
Source: The Lancet. Oncology [Lancet Oncol] 2022 Dec; Vol. 23 (12), pp. 1499-1507. Date of Electronic Publication: 2022 Nov 04.
Publication Type: Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(22)00642-8